1. Immunology/Inflammation
  2. CD19
  3. Duvortuxizumab

Duvortuxizumab  (Synonyms: 度妥昔珠单抗; MGD 011)

目录号: HY-P99868 纯度: ≥99.0%
COA

Duvortuxizumab (MGD 011) 是嵌合人源化的、靶向 CD19CD3E 的 IG 抗体。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CAS No. : 1831098-91-9

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥6000
In-stock
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E[1].

同型

scFv-h-CH2-CH3(_scFv)_h-CH2-CH3

种属

Chimeric; Humanized

CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

度妥昔珠单抗

运输条件

Shipping with dry ice.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • scFv-h-CH2-CH3(_scFv)_h-CH2-CH3
Biological Activity
  • Loaded CD19 Protein, Mouse (HEK293, His, HY-P74328) on AHC2 biosensor, can bind Duvortuxizumab with an affinity constant of <1.000E-11 M as determined in BLI assay.
纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Duvortuxizumab
目录号:
HY-P99868
需求量: